Results 151 to 160 of about 11,438 (231)

[Determination of 65 synthetic cannabinoids in whole blood by QuEChERS-ultra performance liquid chromatography- mass spectrometry]. [PDF]

Se Pu
Xi Z, Ye Y, Li SP, Kang J, Liu WQ, Zhang J, Li DX.   +6 more
europepmc   +1 more source

Accuracy of Patient‐Reported Exposure to New Psychoactive Substances and Other Illicit Drugs in Australian Emergency Departments: Findings From the Emerging Drugs Network of Australia

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction New psychoactive substances (NPS) present a unique challenge in clinical, public health and drug‐policy contexts. Continued diversity, unknown potency and often unintentional exposure can limit the accuracy of self‐reported data.
Marjan J. Nijmeijer, Jennifer L. Smith, Courtney Weber, Bas W. J. Bens, Daniel M. Fatovich, Shaun L. Greene, Jennifer L. Schumann, Paul Dessauer, Rebekka Syrjanen, Katherine Z. Isoardi, Keith Harris, Sam Alfred, Viet Tran, Ewoud ter Avest   +13 more
wiley   +1 more source

Revealing the therapeutic potential of synthetic cannabinoids: a systematic review of cannabinoid receptor binding dynamics and their implications for cancer therapy. [PDF]

J Cannabis Res
Alghamdi SS, Albahlal HN, Aloumi DE, Bin Saqyah S, Alsubait A, Alamre J, Alrashed M, Alsuhabeny N, Mohammed AE.   +8 more
europepmc   +1 more source

International Policy Approaches for Higher THC Cannabis Products: Are They Applicable to the Australian Medicinal Cannabis Framework?

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction There have been concerted research efforts internationally to examine the health effects of higher delta‐9‐tetrahydrocannabinol (THC) concentration cannabis products and to design policies to reduce potential negative health effects of their use.
Myfanwy Graham, Dereje Assefa, Adrian Carter, Suzanne Nielsen   +3 more
wiley   +1 more source

Noncovalent Interaction-Based Probe Design for PET-Facilitated Fluorescence Sensing of Synthetic Cannabinoids. [PDF]

ACS Omega
Dong J, Zhao C, Ning J, Liu Y, Dou X.
europepmc   +1 more source

Discordant Drug Checking Results and Risk Reduction Behaviours: Findings From the ChecKnow Study in France

Drug and Alcohol Review, Volume 45, Issue 5, July 2026.
ABSTRACT Introduction Drug checking services (DCS) provide people with information about the contents of their drugs, reducing uncertainty about the composition of substances from unregulated markets. However, their impact on behaviour change has been sparsely evaluated.
Samuel Tobias, Julio Del Amo, Sophie Albert, Marion Aubert, Anissa Zerrari, Pierre Chappard, Lianping Ti, Perrine Roux   +7 more
wiley   +1 more source

Classification of Mass Spectral Data to Assist in the Identification of Novel Synthetic Cannabinoids. [PDF]

Molecules
Evans-Newman KC, Schneider GL, Perera NT.   +2 more
europepmc   +1 more source

APP/Aβ Signaling Orchestrates Reactive Astrocyte Networks in Alzheimer's Disease

Journal of Neurochemistry, Volume 170, Issue 7, July 2026.
Stress increases astrocyte APP production, generating amyloid‐β (Aβ). Aβ then diffuses to neighboring astrocytes, stimulating further APP and Aβ production and creating a self‐reinforcing cycle. Over time, impaired Aβ clearance leads to its accumulation, chronic inflammation, and contributes to sporadic Alzheimer's disease. ABSTRACT Alzheimer's disease
Gretsen Velezmoro Jauregui, Sophie Coomes, Elizabeth Emmett, Alex Thatcher, Nicole Oyelakin, Maria Čarna, Jana Zelinkova, Jan Sebastian Novotny, Natalie Polakova, Tarun Kuruvilla, Robert Zorec, Alexei Verkhratsky, Vladimir Parpura, David Morgan, Kenneth L. Moya, Clara Limback‐Stokin, Gorazd Bernard Stokin   +16 more
wiley   +1 more source

Age-specific effects of synthetic cannabinoids on cognitive function and hippocampal gene expression in mice: insights from behavioral and molecular correlates. [PDF]

Front Pharmacol
Li K, Chen Y, Xu Y, Pang Y, Bao Y, Zhang S, Shi X, Ran J, Qiao Y, Xu Y, Wang Y, Di B, Xu P.   +12 more
europepmc   +1 more source

Assessment of Abuse Potential of Three Indazole-Carboxamide Synthetic Cannabinoids 5F-ADB, MDMB-4en-PINACA and ADB-4en-PINACA. [PDF]

Int J Mol Sci
Qiao Y, Shi X, Li K, Kuai L, Li X, Di B, Xu P.   +6 more
europepmc   +1 more source